Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
2.
Nat Immunol ; 25(8): 1411-1421, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38997431

ABSTRACT

A subset of individuals exposed to Mycobacterium tuberculosis (Mtb) that we refer to as 'resisters' (RSTR) show evidence of IFN-γ- T cell responses to Mtb-specific antigens despite serially negative results on clinical testing. Here we found that Mtb-specific T cells in RSTR were clonally expanded, confirming the priming of adaptive immune responses following Mtb exposure. RSTR CD4+ T cells showed enrichment of TH17 and regulatory T cell-like functional programs compared to Mtb-specific T cells from individuals with latent Mtb infection. Using public datasets, we showed that these TH17 cell-like functional programs were associated with lack of progression to active tuberculosis among South African adolescents with latent Mtb infection and with bacterial control in nonhuman primates. Our findings suggested that RSTR may successfully control Mtb following exposure and immune priming and established a set of T cell biomarkers to facilitate further study of this clinical phenotype.


Subject(s)
CD4-Positive T-Lymphocytes , Mycobacterium tuberculosis , Tuberculosis , Mycobacterium tuberculosis/immunology , Humans , Animals , Adolescent , Tuberculosis/immunology , Tuberculosis/microbiology , CD4-Positive T-Lymphocytes/immunology , Th17 Cells/immunology , Female , Macaca mulatta , Male , Phenotype , Interferon-gamma/metabolism , Interferon-gamma/immunology , Antigens, Bacterial/immunology , Latent Tuberculosis/immunology , Latent Tuberculosis/microbiology , South Africa , Young Adult , T-Lymphocytes, Regulatory/immunology , Adult
3.
Nat Med ; 29(1): 258-269, 2023 01.
Article in English | MEDLINE | ID: mdl-36604540

ABSTRACT

Antigen-specific, MHC-restricted αß T cells are necessary for protective immunity against Mycobacterium tuberculosis, but the ability to broadly study these responses has been limited. In the present study, we used single-cell and bulk T cell receptor (TCR) sequencing and the GLIPH2 algorithm to analyze M. tuberculosis-specific sequences in two longitudinal cohorts, comprising 166 individuals with M. tuberculosis infection who progressed to either tuberculosis (n = 48) or controlled infection (n = 118). We found 24 T cell groups with similar TCR-ß sequences, predicted by GLIPH2 to have common TCR specificities, which were associated with control of infection (n = 17), and others that were associated with progression to disease (n = 7). Using a genome-wide M. tuberculosis antigen screen, we identified peptides targeted by T cell similarity groups enriched either in controllers or in progressors. We propose that antigens recognized by T cell similarity groups associated with control of infection can be considered as high-priority targets for future vaccine development.


Subject(s)
Mycobacterium tuberculosis , Tuberculosis , Humans , Tuberculosis/genetics , T-Lymphocytes , Receptors, Antigen, T-Cell/genetics , Antigens , Disease Progression
4.
PLoS Negl Trop Dis ; 16(1): e0010102, 2022 01.
Article in English | MEDLINE | ID: mdl-34982773

ABSTRACT

BACKGROUND: COVID-19 caused by SARS-CoV-2 ranges from asymptomatic to severe disease and can cause fatal and devastating outcome in many cases. In this study, we have compared the clinical, biochemical and immunological parameters across the different disease spectrum of COVID-19 in Bangladeshi patients. METHODOLOGY/PRINCIPAL FINDINGS: This longitudinal study was conducted in two COVID-19 hospitals and also around the community in Dhaka city in Bangladesh between November 2020 to March 2021. A total of 100 patients with COVID-19 infection were enrolled and classified into asymptomatic, mild, moderate and severe cases (n = 25/group). In addition, thirty age and sex matched healthy participants were enrolled and 21 were analyzed as controls based on exclusion criteria. After enrollment (study day1), follow-up visits were conducted on day 7, 14 and 28 for the cases. Older age, male gender and co-morbid conditions were the risk factors for severe COVID-19 disease. Those with moderate and severe cases of infection had low lymphocyte counts, high neutrophil counts along with a higher neutrophil-lymphocyte ratio (NLR) at enrollment; this decreased to normal range within 42 days after the onset of symptom. At enrollment, D-dimer, CRP and ferritin levels were elevated among moderate and severe cases. The mild, moderate, and severe cases were seropositive for IgG antibody by day 14 after enrollment. Moderate and severe cases showed significantly higher IgM and IgG levels of antibodies to SARS-CoV-2 compared to mild and asymptomatic cases. CONCLUSION/SIGNIFICANCE: We report on the clinical, biochemical, and hematological parameters associated with the different severity of COVID-19 infection. We also show different profile of antibody response against SARS-CoV-2 in relation to disease severity, especially in those with moderate and severe disease manifestations compared to the mild and asymptomatic infection.


Subject(s)
Antibodies, Viral/immunology , COVID-19/diagnosis , COVID-19/immunology , Severity of Illness Index , Adult , Antibody Formation , Bangladesh , COVID-19 Testing , Cohort Studies , Female , Fibrin Fibrinogen Degradation Products , Humans , Immunoglobulin G , Longitudinal Studies , Lymphocytes , Male , Middle Aged , Neutrophils , Risk Factors , SARS-CoV-2 , Viral Load
5.
Am J Respir Crit Care Med ; 203(12): 1556-1565, 2021 06 15.
Article in English | MEDLINE | ID: mdl-33406011

ABSTRACT

Rationale: Current diagnostic tests fail to identify individuals at higher risk of progression to tuberculosis disease, such as those with recent Mycobacterium tuberculosis infection, who should be prioritized for targeted preventive treatment. Objectives: To define a blood-based biomarker, measured with a simple flow cytometry assay, that can stratify different stages of tuberculosis infection to infer risk of disease. Methods: South African adolescents were serially tested with QuantiFERON-TB Gold to define recent (QuantiFERON-TB conversion <6 mo) and persistent (QuantiFERON-TB+ for >1 yr) infection. We defined the ΔHLA-DR median fluorescence intensity biomarker as the difference in HLA-DR expression between IFN-γ+ TNF+Mycobacterium tuberculosis-specific T cells and total CD3+ T cells. Biomarker performance was assessed by blinded prediction in untouched test cohorts with recent versus persistent infection or tuberculosis disease and by unblinded analysis of asymptomatic adolescents with tuberculosis infection who remained healthy (nonprogressors) or who progressed to microbiologically confirmed disease (progressors). Measurements and Main Results: In the test cohorts, frequencies of Mycobacterium tuberculosis-specific T cells differentiated between QuantiFERON-TB- (n = 25) and QuantiFERON-TB+ (n = 47) individuals (area under the receiver operating characteristic curve, 0.94; 95% confidence interval, 0.87-1.00). ΔHLA-DR significantly discriminated between recent (n = 20) and persistent (n = 22) QuantiFERON-TB+ (0.91; 0.83-1.00); persistent QuantiFERON-TB+ and newly diagnosed tuberculosis (n = 19; 0.99; 0.96-1.00); and tuberculosis progressors (n = 22) and nonprogressors (n = 34; 0.75; 0.63-0.87). However, ΔHLA-DR median fluorescent intensity could not discriminate between recent QuantiFERON-TB+ and tuberculosis (0.67; 0.50-0.84). Conclusions: The ΔHLA-DR biomarker can identify individuals with recent QuantiFERON-TB conversion and those with disease progression, allowing targeted provision of preventive treatment to those at highest risk of tuberculosis. Further validation studies of this novel immune biomarker in various settings and populations at risk are warranted.


Subject(s)
Biomarkers/blood , Latent Tuberculosis/diagnosis , Latent Tuberculosis/immunology , Mycobacterium tuberculosis/immunology , Tuberculosis/diagnosis , Tuberculosis/immunology , Tumor Necrosis Factor Receptor Superfamily, Member 7/blood , Adolescent , Adult , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Male , Middle Aged , Risk Assessment/methods , South Africa , Tuberculin Test/methods , Young Adult
6.
Immunohorizons ; 4(12): 774-788, 2020 12 11.
Article in English | MEDLINE | ID: mdl-33310880

ABSTRACT

The antiviral response to influenza virus is complex and multifaceted, involving many immune cell subsets. There is an urgent need to understand the role of CD4+ T cells, which orchestrate an effective antiviral response, to improve vaccine design strategies. In this study, we analyzed PBMCs from human participants immunized with influenza vaccine, using high-dimensional single-cell proteomic immune profiling by mass cytometry. Data were analyzed using a novel clustering algorithm, denoised ragged pruning, to define possible influenza virus-specific clusters of CD4+ T cells. Denoised ragged pruning identified six clusters of cells. Among these, one cluster (Cluster 3) was found to increase in abundance following stimulation with influenza virus peptide ex vivo. A separate cluster (Cluster 4) was found to expand in abundance between days 0 and 7 postvaccination, indicating that it is vaccine responsive. We examined the expression profiles of all six clusters to characterize their lineage, functionality, and possible role in the response to influenza vaccine. Clusters 3 and 4 consisted of effector memory cells, with high CD154 expression. Cluster 3 expressed cytokines like IL-2, IFN-γ, and TNF-α, whereas Cluster 4 expressed IL-17. Interestingly, some participants had low abundance of Clusters 3 and 4, whereas others had higher abundance of one of these clusters compared with the other. Taken together, we present an approach for identifying novel influenza virus-reactive CD4+ T cell subsets, a method that could help advance understanding of the immune response to influenza, predict responsiveness to vaccines, and aid in better vaccine design.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Immunologic Memory , Influenza Vaccines/immunology , Influenza, Human/prevention & control , T-Lymphocyte Subsets/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Antigens, CD/analysis , Child , Cluster Analysis , Cytokines/metabolism , Female , Flow Cytometry , Humans , Influenza Vaccines/administration & dosage , Influenza, Human/immunology , Male , Middle Aged , Young Adult
7.
Nat Commun ; 11(1): 3738, 2020 07 27.
Article in English | MEDLINE | ID: mdl-32719375

ABSTRACT

High-throughput single-cell analysis technologies produce an abundance of data that is critical for profiling the heterogeneity of cellular systems. We introduce VoPo (https://github.com/stanleyn/VoPo), a machine learning algorithm for predictive modeling and comprehensive visualization of the heterogeneity captured in large single-cell datasets. In three mass cytometry datasets, with the largest measuring hundreds of millions of cells over hundreds of samples, VoPo defines phenotypically and functionally homogeneous cell populations. VoPo further outperforms state-of-the-art machine learning algorithms in classification tasks, and identified immune-correlates of clinically-relevant parameters.


Subject(s)
Algorithms , Models, Biological , Single-Cell Analysis , Cluster Analysis , Databases as Topic , Flow Cytometry , Humans
8.
Pathologe ; 41(4): 334-343, 2020 Jul.
Article in German | MEDLINE | ID: mdl-32347330

ABSTRACT

Lupus erythematosus (LE) is an autoimmune disorder where immune tolerance towards nucleic acids is lost and a hyperactivated type I interferon system drives chronic immune activation. Typically, signs, symptoms, and clinical disease course are very variable between patients. Cutaneous LE can be associated with or precede systemic involvement or be limited to the skin, necessitating careful examination and follow-up of patients. LE skin disease includes a wide range of manifestations and precise classification for clinical studies is challenging. In this review article we discuss common and rare manifestations of cutaneous lupus with its clinical presentation and histopathological characteristics.


Subject(s)
Lupus Erythematosus, Cutaneous , Lupus Erythematosus, Systemic , Humans , Lupus Erythematosus, Cutaneous/diagnosis , Lupus Erythematosus, Systemic/diagnosis
9.
Front Immunol ; 11: 574057, 2020.
Article in English | MEDLINE | ID: mdl-33424833

ABSTRACT

Vi-polysaccharide conjugate vaccines are efficacious against cases of typhoid fever; however, an absolute correlate of protection is not established. In this study, we investigated the leukocyte response to a Vi-tetanus toxoid conjugate vaccine (Vi-TT) in comparison with a plain polysaccharide vaccine (Vi-PS) in healthy adults subsequently challenged with Salmonella Typhi. Immunological responses and their association with challenge outcome was assessed by mass cytometry and Vi-ELISpot assay. Immunization induced significant expansion of plasma cells in both vaccines with modest T follicular helper cell responses detectable after Vi-TT only. The Vi-specific IgG and IgM B cell response was considerably greater in magnitude in Vi-TT recipients. Intriguingly, a significant increase in a subset of IgA+ plasma cells expressing mucosal migratory markers α4ß7 and CCR10 was observed in both vaccine groups, suggesting a gut-tropic, mucosal response is induced by Vi-vaccination. The total plasma cell response was significantly associated with protection against typhoid fever in Vi-TT vaccinees but not Vi-PS. IgA+ plasma cells were not significantly associated with protection for either vaccine, although a trend is seen for Vi-PS. Conversely, the IgA- fraction of the plasma cell response was only associated with protection in Vi-TT. In summary, these data indicate that a phenotypically heterogeneous response including both gut-homing and systemic antibody secreting cells may be critical for protection induced by Vi-TT vaccination.


Subject(s)
Plasma Cells/immunology , Polysaccharides, Bacterial/immunology , Salmonella typhi/immunology , Typhoid Fever/immunology , Typhoid-Paratyphoid Vaccines/immunology , ADP-ribosyl Cyclase 1/metabolism , Adult , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Enzyme-Linked Immunospot Assay , Flow Cytometry , Humans , Immunoglobulin A/metabolism , Immunologic Memory , Lymphocyte Activation , Membrane Glycoproteins/metabolism , Plasma Cells/metabolism , T Follicular Helper Cells/immunology , Tetanus Toxoid/immunology , Typhoid Fever/prevention & control , Vaccination , Vaccines, Conjugate/immunology
10.
J Immunol ; 203(11): 2917-2927, 2019 12 01.
Article in English | MEDLINE | ID: mdl-31611259

ABSTRACT

Tuberculosis (TB) is the leading cause of mortality from a single infectious agent, Mycobacterium tuberculosis Relevant immune targets of the partially efficacious TB vaccine bacille Calmette-Guérin (BCG) remain poorly defined. Mucosal-associated invariant T (MAIT) cells are MHC-related protein 1 (MR1)-restricted T cells, which are reactive against M. tuberculosis, and underexplored as potential TB vaccine targets. We sought to determine whether BCG vaccination activated mycobacteria-specific MAIT cell responses in humans. We analyzed whole blood samples from M. tuberculosis-infected South African adults who were revaccinated with BCG after a six-month course of isoniazid preventative therapy. In vitro BCG stimulation potently induced IFN-γ expression by phenotypic (CD8+CD26+CD161+) MAIT cells, which constituted the majority (75%) of BCG-reactive IFN-γ-producing CD8+ T cells. BCG revaccination transiently expanded peripheral blood frequencies of BCG-reactive IFN-γ+ MAIT cells, which returned to baseline frequencies a year following vaccination. In another cohort of healthy adults who received BCG at birth, 53% of mycobacteria-reactive-activated CD8 T cells expressed CDR3α TCRs, previously reported as MAIT TCRs, expressing the canonical TRAV1-2-TRAJ33 MAIT TCRα rearrangement. CD26 and CD161 coexpression correlated with TRAV1-2+CD161+ phenotype more accurately in CD8+ than CD4-CD8- MAIT cells. Interestingly, BCG-induced IFN-γ expression by MAIT cells in vitro was mediated by the innate cytokines IL-12 and IL-18 more than MR1-induced TCR signaling, suggesting TCR-independent activation. Collectively, the data suggest that activation of blood MAIT cells by innate inflammatory cytokines is a major mechanism of responsiveness to vaccination with whole cell vaccines against TB or in vitro stimulation with mycobacteria (Clinical trial registration: NCT01119521).


Subject(s)
Histocompatibility Antigens Class I/immunology , Minor Histocompatibility Antigens/immunology , Mucosal-Associated Invariant T Cells/immunology , Mycobacterium tuberculosis/immunology , Adolescent , Child , Cohort Studies , Cytokines/immunology , Humans , Receptors, Antigen, T-Cell/immunology
11.
Nat Med ; 25(7): 1082-1088, 2019 07.
Article in English | MEDLINE | ID: mdl-31270506

ABSTRACT

Salmonella Typhi is a human host-restricted pathogen that is responsible for typhoid fever in approximately 10.9 million people annually1. The typhoid toxin is postulated to have a central role in disease pathogenesis, the establishment of chronic infection and human host restriction2-6. However, its precise role in typhoid disease in humans is not fully defined. We studied the role of typhoid toxin in acute infection using a randomized, double-blind S. Typhi human challenge model7. Forty healthy volunteers were randomized (1:1) to oral challenge with 104 colony-forming units of wild-type or an isogenic typhoid toxin deletion mutant (TN) of S. Typhi. We observed no significant difference in the rate of typhoid infection (fever ≥38 °C for ≥12 h and/or S. Typhi bacteremia) between participants challenged with wild-type or TN S. Typhi (15 out of 21 (71%) versus 15 out of 19 (79%); P = 0.58). The duration of bacteremia was significantly longer in participants challenged with the TN strain compared with wild-type (47.6 hours (28.9-97.0) versus 30.3(3.6-49.4); P ≤ 0.001). The clinical syndrome was otherwise indistinguishable between wild-type and TN groups. These data suggest that the typhoid toxin is not required for infection and the development of early typhoid fever symptoms within the context of a human challenge model. Further clinical data are required to assess the role of typhoid toxin in severe disease or the establishment of bacterial carriage.


Subject(s)
Bacterial Toxins/toxicity , Salmonella typhi/pathogenicity , Typhoid Fever/etiology , Acute Disease , Adolescent , Adult , Animals , Double-Blind Method , Humans , Mice , Mice, Inbred C57BL , Middle Aged , Typhoid Fever/immunology , Typhoid Fever/pathology , Young Adult
12.
J Exp Med ; 216(5): 1154-1169, 2019 05 06.
Article in English | MEDLINE | ID: mdl-30962246

ABSTRACT

Systemic lupus erythematosus carries an increased risk of pregnancy complications, including preeclampsia and fetal adverse outcomes. To identify the underlying molecular mechanisms, we longitudinally profiled the blood transcriptome of 92 lupus patients and 43 healthy women during pregnancy and postpartum and performed multicolor flow cytometry in a subset of them. We also profiled 25 healthy women undergoing assisted reproductive technology to monitor transcriptional changes around embryo implantation. Sustained down-regulation of multiple immune signatures, including interferon and plasma cells, was observed during healthy pregnancy. These changes appeared early after embryo implantation and were mirrored in uncomplicated lupus pregnancies. Patients with preeclampsia displayed early up-regulation of neutrophil signatures that correlated with expansion of immature neutrophils. Lupus pregnancies with fetal complications carried the highest interferon and plasma cell signatures as well as activated CD4+ T cell counts. Thus, blood immunomonitoring reveals that both healthy and uncomplicated lupus pregnancies exhibit early and sustained transcriptional modulation of lupus-related signatures, and a lack thereof associates with adverse outcomes.


Subject(s)
Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/genetics , Pregnancy Complications/blood , Pregnancy Complications/genetics , Transcriptome , Adult , Biomarkers , Embryo Implantation/genetics , Female , Humans , Longitudinal Studies , Pre-Eclampsia/genetics , Pregnancy , Prospective Studies , RNA-Seq
13.
Cancer Res ; 78(18): 5243-5258, 2018 09 15.
Article in English | MEDLINE | ID: mdl-30012670

ABSTRACT

Inflammation affects tumor immune surveillance and resistance to therapy. Here, we show that production of IL1ß in primary breast cancer tumors is linked with advanced disease and originates from tumor-infiltrating CD11c+ myeloid cells. IL1ß production is triggered by cancer cell membrane-derived TGFß. Neutralizing TGFß or IL1 receptor prevents breast cancer progression in humanized mouse model. Patients with metastatic HER2- breast cancer display a transcriptional signature of inflammation in the blood leukocytes, which is attenuated after IL1 blockade. When present in primary breast cancer tumors, this signature discriminates patients with poor clinical outcomes in two independent public datasets (TCGA and METABRIC).Significance: IL1ß orchestrates tumor-promoting inflammation in breast cancer and can be targeted in patients using an IL1 receptor antagonist. Cancer Res; 78(18); 5243-58. ©2018 AACRSee related commentary by Dinarello, p. 5200.


Subject(s)
Breast Neoplasms/metabolism , Gene Expression Regulation, Neoplastic , Interleukin 1 Receptor Antagonist Protein/metabolism , Interleukin-1beta/metabolism , Transcription, Genetic , Animals , Breast Neoplasms/drug therapy , CD11c Antigen/metabolism , Capecitabine/administration & dosage , Cell Line, Tumor , Cell Membrane/metabolism , Female , Furans/administration & dosage , Humans , Inflammation , Interleukin 1 Receptor Antagonist Protein/administration & dosage , Ketones/administration & dosage , Leukocytes, Mononuclear/cytology , Macrophages/metabolism , Mice , Mice, SCID , Myeloid Cells/metabolism , Neoplasm Metastasis , Neoplasm Transplantation , Paclitaxel/administration & dosage , Pilot Projects , Transforming Growth Factor beta/metabolism
14.
J Immunol Methods ; 453: 37-43, 2018 02.
Article in English | MEDLINE | ID: mdl-29174717

ABSTRACT

For more than five years, high-dimensional mass cytometry has been employed to study immunology. However, these studies have typically been performed in one laboratory on one or few instruments. We present the results of a six-center study using healthy control human peripheral blood mononuclear cells (PBMCs) and commercially available reagents to test the intra-site and inter-site variation of mass cytometers and operators. We used prestained controls generated by the primary center as a reference to compare against samples stained at each individual center. Data were analyzed at the primary center, including investigating the effects of two normalization methods. All six sites performed similarly, with CVs for both Frequency of Parent and median signal intensity (MSI) values<30%. Increased background was seen when using the premixed antibody cocktail aliquots at each site, suggesting that cocktails are best made fresh. Both normalization methods tested performed adequately for normalizing MSI values between centers. Clustering algorithms revealed slight differences between the prestained and the sites-stained samples, due mostly to the increased background of a few antibodies. Therefore, we believe that multicenter mass cytometry assays are feasible.


Subject(s)
Flow Cytometry/methods , Leukocytes, Mononuclear/physiology , Mass Spectrometry/methods , Antibodies/metabolism , Healthy Volunteers , Humans , Immunophenotyping , Pilot Projects , Reference Standards
15.
J Exp Med ; 214(11): 3449-3466, 2017 Nov 06.
Article in English | MEDLINE | ID: mdl-28935693

ABSTRACT

The etiology of sporadic human chronic inflammatory diseases remains mostly unknown. To fill this gap, we developed a strategy that simultaneously integrates blood leukocyte responses to innate stimuli at the transcriptional, cellular, and secreted protein levels. When applied to systemic juvenile idiopathic arthritis (sJIA), an autoinflammatory disease of unknown etiology, this approach identified gene sets associated with specific cytokine environments and activated leukocyte subsets. During disease remission and off treatment, sJIA patients displayed dysregulated responses to TLR4, TLR8, and TLR7 stimulation. Isolated sJIA monocytes underexpressed the IL-1 inhibitor aryl hydrocarbon receptor (AHR) at baseline and accumulated higher levels of intracellular IL-1ß after stimulation. Supporting the demonstration that AHR down-regulation skews monocytes toward macrophage differentiation, sJIA monocytes differentiated in vitro toward macrophages, away from the dendritic cell phenotype. This might contribute to the increased incidence of macrophage activation syndrome in these patients. Integrated analysis of high-dimensional data can thus unravel immune alterations predisposing to complex inflammatory diseases.


Subject(s)
Arthritis, Juvenile/genetics , Cell Differentiation/genetics , Macrophages/metabolism , Monocytes/metabolism , Adult , Arthritis, Juvenile/blood , Arthritis, Juvenile/immunology , Blotting, Western , Cell Differentiation/drug effects , Cell Differentiation/immunology , Cytokines/blood , Cytokines/genetics , Cytokines/immunology , Enzyme-Linked Immunosorbent Assay , Gene Expression Profiling/methods , Humans , Interleukin-1beta/blood , Interleukin-1beta/genetics , Interleukin-1beta/immunology , Ligands , Lipopolysaccharides/immunology , Lipopolysaccharides/pharmacology , Macrophages/immunology , Monocytes/immunology , Reverse Transcriptase Polymerase Chain Reaction
17.
Sci Rep ; 6: 26494, 2016 05 27.
Article in English | MEDLINE | ID: mdl-27231124

ABSTRACT

The immune mechanism leading to the generation of protective antibody responses following influenza trivalent inactivated vaccine (TIV) vaccinations remains largely uncharacterized. We recently reported that TIV vaccination induced a transient increase of circulating ICOS(+)PD-1(+)CXCR3(+) T follicular helper (cTfh) cells in blood, which positively correlated with the induction of protective antibody responses measured at day 28. However, whether and how these T cells directly contribute to antibody response remains unclear. In this study, we analyzed the changes after TIV vaccination in the amount and the avidity of the polyclonal antibodies specific for the HA1 subunit of the pandemic H1N1 virus, and analyzed the correlation with the increase of ICOS(+)PD-1(+)CXCR3(+) cTfh cells. We found that both the amount and the avidity of specific antibodies rapidly increased during the first 7 days after TIV. Importantly, the increase of ICOS(+)PD-1(+)CXCR3(+) cTfh cells strongly correlated with the increase in the avidity of antibodies, particularly in subjects who did not have high affinity antibodies at baseline. We propose that ICOS(+)PD-1(+)CXCR3(+) Tfh cells directly contribute to the generation of high-avidity antibodies after TIV vaccinations by selectively interacting with high affinity B cells at extrafollicular sites.


Subject(s)
Antibodies, Viral/blood , Influenza A Virus, H1N1 Subtype/immunology , Influenza Vaccines/immunology , Influenza, Human/immunology , T-Lymphocytes, Helper-Inducer/immunology , Antibody Affinity , Antibody Specificity , Antigens, Viral/immunology , B-Lymphocytes/immunology , Humans , Inducible T-Cell Co-Stimulator Protein/metabolism , Influenza, Human/blood , Influenza, Human/prevention & control , Programmed Cell Death 1 Receptor/metabolism , Receptors, CXCR3/metabolism , T-Lymphocytes, Helper-Inducer/metabolism , T-Lymphocytes, Helper-Inducer/virology , Vaccination
18.
Cell ; 165(3): 551-65, 2016 Apr 21.
Article in English | MEDLINE | ID: mdl-27040498

ABSTRACT

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of tolerance to nucleic acids and highly diverse clinical manifestations. To assess its molecular heterogeneity, we longitudinally profiled the blood transcriptome of 158 pediatric patients. Using mixed models accounting for repeated measurements, demographics, treatment, disease activity (DA), and nephritis class, we confirmed a prevalent IFN signature and identified a plasmablast signature as the most robust biomarker of DA. We detected gradual enrichment of neutrophil transcripts during progression to active nephritis and distinct signatures in response to treatment in different nephritis subclasses. Importantly, personalized immunomonitoring uncovered individual correlates of disease activity that enabled patient stratification into seven groups, supported by patient genotypes. Our study uncovers the molecular heterogeneity of SLE and provides an explanation for the failure of clinical trials. This approach may improve trial design and implementation of tailored therapies in genetically and clinically complex autoimmune diseases. PAPERCLIP.


Subject(s)
Lupus Erythematosus, Systemic/genetics , Adolescent , Child , Female , Humans , Longitudinal Studies , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/pathology , Lupus Erythematosus, Systemic/therapy , Lupus Nephritis/genetics , Lupus Nephritis/immunology , Neutrophils/immunology , Polymorphism, Single Nucleotide , Precision Medicine , Transcriptome
19.
Sci Rep ; 6: 20686, 2016 Feb 10.
Article in English | MEDLINE | ID: mdl-26861911

ABSTRACT

Standardization of immunophenotyping requires careful attention to reagents, sample handling, instrument setup, and data analysis, and is essential for successful cross-study and cross-center comparison of data. Experts developed five standardized, eight-color panels for identification of major immune cell subsets in peripheral blood. These were produced as pre-configured, lyophilized, reagents in 96-well plates. We present the results of a coordinated analysis of samples across nine laboratories using these panels with standardized operating procedures (SOPs). Manual gating was performed by each site and by a central site. Automated gating algorithms were developed and tested by the FlowCAP consortium. Centralized manual gating can reduce cross-center variability, and we sought to determine whether automated methods could streamline and standardize the analysis. Within-site variability was low in all experiments, but cross-site variability was lower when central analysis was performed in comparison with site-specific analysis. It was also lower for clearly defined cell subsets than those based on dim markers and for rare populations. Automated gating was able to match the performance of central manual analysis for all tested panels, exhibiting little to no bias and comparable variability. Standardized staining, data collection, and automated gating can increase power, reduce variability, and streamline analysis for immunophenotyping.


Subject(s)
Flow Cytometry/standards , Immunophenotyping/standards , Laboratories/standards , Algorithms , Automation , B-Lymphocytes/cytology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Flow Cytometry/methods , Humans , Immunophenotyping/methods , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
20.
Nat Commun ; 5: 5283, 2014 Oct 22.
Article in English | MEDLINE | ID: mdl-25335753

ABSTRACT

The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines.


Subject(s)
Dendritic Cells/cytology , Dendritic Cells/microbiology , Transcription, Genetic , Vaccines/chemistry , Algorithms , Animals , Antigens, CD1/metabolism , Antigens, Surface/metabolism , Cluster Analysis , Cytokines/metabolism , Dendritic Cells/metabolism , Dogs , Gene Expression Profiling , Glycoproteins/metabolism , Humans , Influenza A Virus, H1N1 Subtype , Interleukin-4/metabolism , Madin Darby Canine Kidney Cells , Monocytes/cytology , Monocytes/metabolism , Principal Component Analysis , Salmonella enterica , Staphylococcus aureus , Thrombomodulin , Transcriptome
SELECTION OF CITATIONS
SEARCH DETAIL